- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Treatment of Relapsed Acute Lymphocytic Leukemia in Adult Patients ; volume:25 ; number:8 ; day:25 ; month:6 ; year:2024 ; pages:993-1010 ; date:8.2024
Current treatment options in oncology ; 25, Heft 8 (25.6.2024), 993-1010, 8.2024
- Urheber
-
Molina, John C.
Carraway, Hetty E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11864-024-01213-4
- URN
-
urn:nbn:de:101:1-2411032113494.160588394913
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Molina, John C.
- Carraway, Hetty E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Relapsed Acute Lymphoblastic Leukemia
Update on the management of relapsed/refractory chronic lymphocytic leukemia
Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
Treatment of Relapsed Acute Myeloid Leukemia
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
FLT3 mutations in canine acute lymphocytic leukemia
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia
Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Relapsed Acute Lymphoblastic Leukemia
Update on the management of relapsed/refractory chronic lymphocytic leukemia
Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
Treatment of Relapsed Acute Myeloid Leukemia
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
FLT3 mutations in canine acute lymphocytic leukemia
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia
Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Relapsed Acute Lymphoblastic Leukemia
Update on the management of relapsed/refractory chronic lymphocytic leukemia
Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
Treatment of Relapsed Acute Myeloid Leukemia
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
FLT3 mutations in canine acute lymphocytic leukemia
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia
Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia